Adaptive Methods: When and How Should They be Used in Clinical Trials?
Therapie, 66 4 (2011) 319-326
Published online: 2011-08-19
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gaps
Katie H. Thomson, Opeyemi Agbeleye, Chizoba Oparah, Alex Inskip, Matthew Breckons, Michelle Bardgett, Alex Bevin-Nicholls, Helen Hancock, Helen Mossop, Julia Phillipson, Dawn Teare, Zoe Walmsley, Nina Wilson, Dawn Craig and James M. S. WasonTrials 27 (1) (2026)
https://doi.org/10.1186/s13063-026-09643-1
Adaptive design trials in eating disorder research: A scoping review
Laura C. Edney and Mia L. PellizzerInternational Journal of Eating Disorders 57 (6) 1278 (2024)
https://doi.org/10.1002/eat.24198
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.BMJ m115 (2020)
https://doi.org/10.1136/bmj.m115
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.Trials 21 (1) (2020)
https://doi.org/10.1186/s13063-020-04334-x
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
Munyaradzi Dimairo, Elizabeth Coates, Philip Pallmann, et al.BMC Medicine 16 (1) (2018)
https://doi.org/10.1186/s12916-018-1196-2
Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology
Joëlle Micallef, Pierre Boutouyrie and Olivier BlinFundamental & Clinical Pharmacology 31 (6) 685 (2017)
https://doi.org/10.1111/fcp.12314